Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bovine insulin soluble-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |
Bovine insulin soluble-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |
Product containing precisely beef insulin (as bovine insulin soluble) 150 unit/1.5 milliliter conventional release solution for injection cartridge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |
Product containing precisely beef insulin (as bovine insulin soluble) 1000 unit/10 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |
Bovine insulin soluble only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |
Bovine insulin soluble only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |
Product containing precisely beef insulin (as bovine insulin soluble) 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |
Bovine insulin soluble 100 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |
Bovine insulin soluble 100 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bovine insulin soluble |
Inferred relationship |
Some |
1 |